| Pegasys (pegylated interferon α -2a) / Roche |
NCT01311947: Hepatitis B Virus Mutants and the Therapeutic Effect of Peginterferon Alfa-2a in HBeAg-Positive Chronic Hepatitis B |
|
|
| Completed | N/A | 103 | RoW | Peginterferon alfa-2a, Pegasys | China Medical University Hospital | Hepatitis B, Chronic | 03/12 | 03/12 | | |
NCT01734018: An Observational Study of Pegasys (Peginterferon Alfa-2a) in Patients With HBeAg-Positive or HBeAg-Negative Chronic Hepatitis B |
|
|
| Completed | N/A | 50 | Europe | | Hoffmann-La Roche | Hepatitis B, Chronic | 08/12 | 08/12 | | |
NCT01645969: A Follow-Up Study of Patients With HBeAg Positive Chronic Hepatitis B Treated With Pegasys (Peginterferon Alfa-2a) in Study ML22265 |
|
|
| Completed | N/A | 65 | RoW | | Hoffmann-La Roche | Hepatitis B, Chronic | 10/12 | 10/12 | | |
NCT01283074: An Observational Study of Pegasys (Peginterferon Alfa-2a) in Patients With HbeAg-negative Chronic Hepatitis B (Perseas) |
|
|
| Completed | N/A | 107 | Europe | | Hoffmann-La Roche | Hepatitis B, Chronic | 11/12 | 11/12 | | |
NCT01471535: HBsAg Clearance in Inactive Chronic HBsAg Carriers After Interferon Treated |
|
|
| Completed | N/A | 20 | RoW | Pegylated interferon alfa-2a, Pegasys®; Roche, Basel, Switzerland | Beijing Ditan Hospital | Chronic Hepatitis B | 12/12 | 12/12 | | |
NCT01705704: A Retrospective Biomarker Study of Stored Samples Obtained From Patients With Chronic Hepatitis B |
|
|
| Completed | N/A | 269 | Europe, RoW | | Hoffmann-La Roche | Hepatitis B, Chronic | 02/13 | 02/13 | | |
NCT01886300: An Observational Study of Pegasys (Peginterferon Alfa-2a) in Patients With HBeAg-Positive Chronic Hepatitis B in Vietnam |
|
|
| Terminated | N/A | 16 | RoW | | Hoffmann-La Roche | Hepatitis B, Chronic | 05/13 | 05/13 | | |
NCT01794234: An Observational Study of Pegasys (Peginterferon Alfa-2a) in Patients With Chronic Hepatitis B Who Have Failed Antiviral Treatment With Nucleoside (Nucleotide) Analogues |
|
|
| Terminated | N/A | 44 | Europe | | Hoffmann-La Roche | Hepatitis B, Chronic | 09/13 | 09/13 | | |
NCT01531166: A Cohort Study in Korean Patients With Chronic Hepatitis B (CHB) Receiving Pegylated Interferon |
|
|
| Completed | N/A | 500 | RoW | pegylated Interferon-alpha 2a, Pegasys | Yonsei University | Chronic Hepatitis B | 08/14 | 10/14 | | |
NCT01667432: An Observational Study of Peginterferon Alfa-2a (PEGASYS®) in Patients With HBeAg Positive or HBeAg Negative Chronic Hepatitis B |
|
|
| Completed | N/A | 141 | Europe | Peginterferon alfa-2a, PEGASYS®, RO0258310 | Hoffmann-La Roche | Hepatitis B, Chronic | 08/14 | 08/14 | | |
NCT01011738: An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys |
|
|
| Completed | N/A | 1842 | Europe, RoW | | Hoffmann-La Roche | Hepatitis B, Chronic | 11/14 | 11/14 | | |
NCT01855997 / 2013-001141-14: A Study to Collect Blood Biomarker Samples From Participants With Chronic Hepatitis B (CHB) Who Received Treatment With Pegasys (Peginterferon Alfa-2a) ± Nucleoside/Nucleotide Analogue |
|
|
| Completed | N/A | 1669 | Europe, RoW | Peg-IFN alfa-2a, Pegasys | Hoffmann-La Roche | Hepatitis B, Chronic | 11/14 | 11/14 | | |
NCT02201407: An Observational Study in Participants With Chronic Hepatitis B (CHB) Receiving Therapy With Peginterferon Alfa-2a 40 Kilodaltons (kD) (PEGASYS) - The PRO B Study |
|
|
| Completed | N/A | 50 | RoW | Peginterferon alfa-2a, PEGASYS | Hoffmann-La Roche | Hepatitis B, Chronic | 04/17 | 04/17 | | |
NCT01730508: An Observational Study of Pegasys (Peginterferon Alfa-2a) in Chinese Patients With HBeAg Negative Chronic Hepatitis B |
|
|
| Completed | N/A | 978 | RoW | Pegylated Interferon Alfa (Peginterferon Alfa), Pegasys | Hoffmann-La Roche | Hepatitis B, Chronic | 06/17 | 06/17 | | |
